双胍全球市场规模研究和预测：按类型（二甲双胍 IR、二甲双胍 ER、其他双胍）、按剂型（片剂、溶液）、区域分析，2022-2029 年

双胍类药物用于治疗 2 型糖尿病。

它的作用是抑制消化过程中产生的葡萄糖。 包括 Glucophage（二甲双胍）、Glucophage XR（二甲双胍缓释片）、Fortamet、Grumezza 和 Riomet。 由于糖尿病患者增加和医疗保健支出增加等因素，双胍类药物的市场正在扩大。

根据国际糖尿病联合会 (IDF) 2021 年版的数据，患有糖尿病的成人人数约为 5.37 亿，预计到 2030 年将增至 6.43 亿。 肥胖、不健康的饮食和缺乏运动导致新诊断的 1 型和 2 型糖尿病的增加。 与此同时，技术创新和进步，以及抗生素使用的增加，正在为市场创造有利可图的机会。 然而，替代品的威胁阻碍了整个 2022-2029 年预测期内的市场增长。

全球双胍市场研究考虑的主要区域包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于糖尿病人口增加、抗药使用增加以及医疗保健成本上升，亚太地区在收入方面占据市场主导地位。 另一方面，由于市场进入者数量增加和研发活动增加等因素，预计亚太地区在预测期内将显着增长。

这项研究的目的是揭示近年来各个细分市场和国家/地区的市场规模，并预测未来几年的市场规模。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还包含供利益相关者投资的微观市场潜在机会，以及对主要参与者的竞争格局和产品供应的深入分析。

内容

第 1 章执行摘要

• 市场概况
• 2019-2029 年按全球市场和细分划分的市场估计和预测
  • 双胍类市场：按地区划分，2019-2029 年
  • 双胍类市场：按类型分类，2019-2029 年
  • 双胍市场：按配方分类，2019-2029 年
• 主要趋势
• 调查方法
• 调查先决条件

第 2 章双胍全球市场定义和范围

• 调查的目的
• 市场定义和范围
  • 调查范围
  • 工业发展
• 调查年份
• 货币兑换率

第3章全球双胍类药物市场动态

• 双胍类药物市场影响分析（2019-2029）
  • 市场驱动力
    • 糖尿病患者增加
    • 医疗支出增加
  • 市场挑战
    • 替代品的威胁
  • 市场机会
    • 创新与进步
    • 增加抗生素的使用

第四章全球双胍市场行业分析

• 波特 5 力模型
  • 供应商的议价能力
  • 买家的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争公司之间的敌对关係
• 波特 5 力模型的未来方法 (2019-2029)
• 害虫分析
  • 政治
  • 经济的
  • 社交
  • 技术
• 投资招聘模式
• 分析师的结论和建议
• 顶级投资机会
• 关键成功策略

第 5 章风险评估 COVID-19 影响

• 评估 COVID-19 对行业的总体影响
• COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球双胍市场，按类型

• 市场概况
• 按类型分列的双胍类全球市场表现 - 潜力分析
• 2019-2029 年全球双胍市场、按类型估算和预测
• 双胍类药物市场、细分市场分析
  • 二甲双胍红外
  • 二甲双胍缓释片
  • 其他双胍

第 7 章：全球双胍市场：按配方分类

• 市场概况
• 全球双胍市场：按剂型进行性能潜力分析
• 双胍全球市场、按配方估算和预测 (2019-2029)
• 双胍市场、细分市场分析
  • 药片
  • 解决方案

第 8 章全球双胍市场：区域分析

• 双胍全球市场、区域市场概况
• 北美
  • 美国
    • 按类型估算和预测，2019-2029 年
    • 按剂型估算和预测，2019-2029 年
  • 加拿大
• 欧洲双胍市场概况
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 意大利
  • 其他欧洲地区
• 亚太双胍市场概况
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 韩国
  • 其他亚太地区
• 拉丁美洲双胍类药物市场概况
  • 巴西
  • 墨西哥
• 世界其他地区

第 9 章衝突信息

• 顶级市场策略
• 公司简介
  • Teva
    • 主要信息
    • 概览
    • 财务信息（取决于数据可用性）
    • 产品概述
    • 近期趋势
  • Merck
  • Takeda
  • GlaxoSmithKline
  • Sanofi
  • Boehringer Ingelheim Pharmaceuticals
  • Glenmark
  • AstraZeneca
  • Bristol-Myers Squibb
  • Aarti Drugs Ltd.

第 10 章研究过程

• 研究过程
  • 数据挖掘
  • 分析
  • 市场评估
  • 验证
  • 出版
• 调查属性
• 调查先决条件

Global Biguanides Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Biguanides are medications used for the treatment of type 2 diabetes. It works by reducing the glucose production that occurs during digestion. It includes Glucophage (metformin) and Glucophage XR (metformin extended release), Fortamet, Glumetza, and Riomet. The Biguanides market is expanding because of factors such as the rising cases of diabetic patients and growing healthcare expenditure

According to International Diabetes Federation (IDF) 2021, the adult diabetes population will be around 537 million in 2021, rising to 643 million by 2030. Obesity, an unhealthy diet, and physical inactivity are all contributing to an increase in newly diagnosed Type 1 and Type 2 diabetes cases. Whereas rising technological innovations and advancement & growing usage of anti-biotic drugs create lucrative opportunities for the market. However, the threat of substitutes hampers the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Biguanides Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. The Asia Pacific dominated the market in terms of revenue, owing to the increasing cases of diabetic patients, growing adoption of anti-drugs, and rising healthcare expenditure. Whereas the Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as the growing penetration of market players and rising R&D activities.

Major market players included in this report are:

Teva

Merck

Takeda

GlaxoSmithKline

Sanofi

Boehringer Ingelheim Pharmaceuticals

Glenmark

AstraZeneca

Bristol-Myers Squibb

Aarti Drugs Ltd.

Recent Developments in the Market:

• In July 2021, In India, the Drug Pricing Authority (NPPA) set retail prices for 84 drug formulations, including those used to treat diabetes, headaches, and high blood pressure. A single tablet of (SR) Metformin Hydrochloride will cost Rs 10.47, excluding GST, according to the order.
• In July 2022, Glenmark Pharmaceuticals Limited has made sitagliptin and its Fixed Dose Combinations (FDCs) with metformin and other anti-diabetic drugs available at a low cost to adults with Type 2 diabetes. Each of these brands will have two variants: SITAZIT M (50 mg) + metformin (500 mg/1000 mg); SITAZIT M ER (100 mg) + metformin SR (500 mg/1000 mg). These medications have a low risk of hypoglycemia, protect beta cells, provide cardio-renal benefits, and are safe for patients with kidney or liver disease as well as seniors.

Global Biguanides Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Type, Dosage Form, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Metformin IR,

Metformin ER,

Other Biguanide

By Dosage Form:

Tablets

Solution

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Biguanides Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Biguanides Market, by Type, 2019-2029 (USD Billion)
  • 1.2.3. Biguanides Market, by Dosage Form, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Biguanides Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Biguanides Market Dynamics

• 3.1. Biguanides Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising cases of diabetic patients
    • 3.1.1.2. Growing healthcare expenditure
  • 3.1.2. Market Challenges
    • 3.1.2.1. Threat of substitute
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Technological innovations and advancements
    • 3.1.3.2. Growing usage of anti-biotic drugs

Chapter 4. Global Biguanides Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Biguanides Market, by Type

• 6.1. Market Snapshot
• 6.2. Global Biguanides Market by Type, Performance - Potential Analysis
• 6.3. Global Biguanides Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
• 6.4. Biguanides Market, Sub Segment Analysis
  • 6.4.1. Metformin IR,
  • 6.4.2. Metformin ER,
  • 6.4.3. Other Biguanide

Chapter 7. Global Biguanides Market, by Dosage Form

• 7.1. Market Snapshot
• 7.2. Global Biguanides Market by Dosage Form, Performance - Potential Analysis
• 7.3. Global Biguanides Market Estimates & Forecasts by Dosage Form 2019-2029 (USD Billion)
• 7.4. Biguanides Market, Sub Segment Analysis
  • 7.4.1. Tablets
  • 7.4.2. Solution

Chapter 8. Global Biguanides Market, Regional Analysis

• 8.1. Biguanides Market, Regional Market Snapshot
• 8.2. North America Biguanides Market
  • 8.2.1. U.S. Biguanides Market
    • 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. Dosage Form breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Biguanides Market
• 8.3. Europe Biguanides Market Snapshot
  • 8.3.1. U.K. Biguanides Market
  • 8.3.2. Germany Biguanides Market
  • 8.3.3. France Biguanides Market
  • 8.3.4. Spain Biguanides Market
  • 8.3.5. Italy Biguanides Market
  • 8.3.6. Rest of Europe Biguanides Market
• 8.4. Asia-Pacific Biguanides Market Snapshot
  • 8.4.1. China Biguanides Market
  • 8.4.2. India Biguanides Market
  • 8.4.3. Japan Biguanides Market
  • 8.4.4. Australia Biguanides Market
  • 8.4.5. South Korea Biguanides Market
  • 8.4.6. Rest of Asia Pacific Biguanides Market
• 8.5. Latin America Biguanides Market Snapshot
  • 8.5.1. Brazil Biguanides Market
  • 8.5.2. Mexico Biguanides Market
• 8.6. Rest of The World Biguanides Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Teva
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Merck
  • 9.2.3. Takeda
  • 9.2.4. GlaxoSmithKline
  • 9.2.5. Sanofi
  • 9.2.6. Boehringer Ingelheim Pharmaceuticals
  • 9.2.7. Glenmark
  • 9.2.8. AstraZeneca
  • 9.2.9. Bristol-Myers Squibb
  • 9.2.10. Aarti Drugs Ltd.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Biguanides Market, report scope
• TABLE 2. Global Biguanides Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Biguanides Market estimates & forecasts by Type 2019-2029 (USD Billion)
• TABLE 4. Global Biguanides Market estimates & forecasts by Dosage Form 2019-2029 (USD Billion)
• TABLE 5. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. U.S. Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. Canada Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 19. Canada Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. Canada Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. UK Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 22. UK Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. UK Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. Germany Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 25. Germany Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. Germany Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. France Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 28. France Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. France Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. Italy Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 31. Italy Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Italy Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Spain Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 34. Spain Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. Spain Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. RoE Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 37. RoE Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. RoE Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. China Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 40. China Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. China Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. India Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 43. India Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. India Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. Japan Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 46. Japan Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. Japan Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. South Korea Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 49. South Korea Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. South Korea Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. Australia Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 52. Australia Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. Australia Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. Brazil Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 58. Brazil Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Brazil Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Mexico Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 61. Mexico Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. Mexico Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. RoLA Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 64. RoLA Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. RoLA Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. Row Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 67. Row Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. Row Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global Biguanides Market
• TABLE 70. List of primary sources, used in the study of global Biguanides Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Biguanides Market, research methodology
• FIG 2. Global Biguanides Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Biguanides Market, key trends 2021
• FIG 5. Global Biguanides Market, growth prospects 2022-2029
• FIG 6. Global Biguanides Market, porters 5 force model
• FIG 7. Global Biguanides Market, pest analysis
• FIG 8. Global Biguanides Market, value chain analysis
• FIG 9. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Biguanides Market, regional snapshot 2019 & 2029
• FIG 15. North America Biguanides Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Biguanides Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Biguanides Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Biguanides Market 2019 & 2029 (USD Billion)
• FIG 19. Global Biguanides Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable